Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth Life Science Investing
HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors Life Science Investing
Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026 Life Science Investing
Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology and United European Gastroenterology Medical Conferences Life Science Investing
Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call Life Science Investing
Sionna Therapeutics to Present Data at the 2026 North American Cystic Fibrosis Conference Life Science Investing
Rua Bioscience and PharmAla Biotech partner to supply medicinal MDMA in New Zealand Life Science Investing
AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting Life Science Investing
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus Development Program Life Science Investing
Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
